W. L. Gore & Associates, Inc. and Gore Medical announced final results of a long-term, prospective, multicenter study evaluating the use of GORE BIO-A Tissue Reinforcement, a bioabsorbable mesh.
The mesh was used in .ventral hernia repair in patients with contaminated fields. Michael Rosen, MD, Cleveland Clinic, the lead investigator of the study, published the research in the
Patients scheduled to undergo CVH repair often have a poor quality of life because of a non-healing abdominal wound. With a sample size of more than 100 patients, these study results showed improved quality of life and a favorable hernia recurrence rate of only 17 percent after 24 months when using the GORE BIO-A Tissue Reinforcement.
“I think this study represents an important step forward in defining the most appropriate way to reconstruct complex abdominal wall defects,” said Dr. Rosen. “Bio A performed very well in this challenging group of patients and will provide a cost-effective alternative for reconstructive surgeons.”
GORE BIO-A Tissue Reinforcement is a web of biocompatible synthetic polymers that is gradually absorbed by the body,
Gore Medical, based in Flagstaff, AZ, is part of W.L. Gore and Associates, Newark and accounts for a sizable percentage of sales for company.
Products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the U.S. “100 Best Companies to Work For” lists since the rankings debuted in 1984. Further information is available at www.goremedical.com.
